4L

Teladoc Health IncFRA Teladoc Stock Report

Last reporting period 30 Sep, 2024

Updated 12 Nov, 2024

Last price

Market cap $B

1.51

Small

Exchange

XFRA - Deutsche Boerse AG

4LL.F Stock Analysis

4L

Uncovered

Teladoc Health Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-19/100

Low score

Market cap $B

1.51

Dividend yield

Shares outstanding

162.62 B

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. The company is headquartered in Purchase, New York and currently employs 5,600 full-time employees. The company went IPO on 2015-07-01. The firm operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Its Integrated Care segment includes a range of global virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. The company offers its integrated care services primarily on a business-to-business (B2B) basis. Its BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 30,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its consumer brands include Teladoc, Livongo by Teladoc Health, and BetterHelp, which delivers access to advice and resolution for a range of healthcare needs.

View Section: Eyestock Rating